X0206 3 2024-01-01 0 0001719714 Mereo Biopharma Group plc MREO 0001201256 WYZGA MICHAEL S C/O MEREO BIOPHARMA GROUP PLC 4TH FLOOR, ONE CAVENDISH PLACE LONDON X0 W1G 0QF UNITED KINGDOM 1 0 0 0 Share Options (Right to buy) 5.40 2029-05-20 American Depositary Shares 5500 D Share Options (Right to buy) 3.00 2029-07-23 American Depositary Shares 5500 D Share Options (Right to buy) 1.84 2030-02-20 American Depositary Shares 11000 D Share Options (Right to buy) 2.72 2031-02-01 American Depositary Shares 31500 D Share Options (Right to buy) 1.31 2032-02-01 American Depositary Shares 55000 D Share Options (Right to buy) 0.94 2033-02-01 American Depositary Shares 55000 D Deferred Restricted Stock Units American Depositary Shares 217296 D Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. This award is fully vested and exercisable. Vests in substantially equal monthly installments over a one year period from the February 1, 2023 grant date. Each deferred restricted stock unit ("DRSU") was granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service. Exhibit 24 - Power of Attorney /s/ Christine Fox, by power of attorney 2024-01-02